Sinus Tachyarrhythmias and the Specific Bradycardic Agents: A Marriage Made in Heaven?

@article{Yusuf2003SinusTA,
  title={Sinus Tachyarrhythmias and the Specific Bradycardic Agents: A Marriage Made in Heaven?},
  author={Shamil Yusuf and A John Camm},
  journal={Journal of Cardiovascular Pharmacology and Therapeutics},
  year={2003},
  volume={8},
  pages={105 - 89}
}
  • S. Yusuf, A. Camm
  • Published 1 June 2003
  • Medicine
  • Journal of Cardiovascular Pharmacology and Therapeutics
A relatively novel group of drugs that inhibit the funny current in the sinus node pacemaker cells, the so-called specific bradycardic agents, are likely to play a significant role in the management of a wide range of cardiovascular disorders, including the sinus tachyarrhythmias. This comprehensive review initially provides an insight into these agents, their historical background, and their mechanism of action. It then discusses the differential diagnosis of the sinus tachyarrhythmias (normal… 

Figures and Tables from this paper

Atrial Tachyarrhythmias and Atrial Flutter: the Basics of Diagnostics and Modern Opportunities of Therapy
TLDR
A critical analysis of traditional approaches to the treatment of atrial tachyarrhythmias is provided and new recommendations for the management of these patients presented in Europe and the USA are given.
The sinus tachycardias
  • S. Yusuf, A. Camm
  • Medicine
    Nature Clinical Practice Cardiovascular Medicine
  • 2005
TLDR
Accurate diagnosis and appropriate therapy of the sinus tachycardias not only prevents multiple consultations but might also have important long-term prognostic implications.
Deciphering the sinus tachycardias
TLDR
There may be prognostic implications for prolonged or recurrent sinus tachycardia, making it imperative that this group of arrhythmias receive adequate and appropriate attention.
Inappropriate Sinus Tachycardia: Current Therapeutic Options
TLDR
The treatment of IST aims to target the multiple mechanisms involved in this disease, and multidisciplinary management, including cardiac rehabilitation, pharmacotherapy, and occasionally radiofrequency modification of the sinus node, should be considered.
Funny current in cardiac pacemaker cells and its specific inhibitor ivabradine
TLDR
Ivabradine is the most specific and selective If inhibitor and the only member of this family that is now marketed for pharmacological treatment of chronic stable angina in patients with normal sinus rhythm who have a contraindication or intolerance to beta-blockers.
Drug-Induced, Drug-Provoked and Drug-Associated Bradycardia
TLDR
Clinical significant and symptomatic bradycardia responsible for the development of syncope, near-syncope, and confusional state are discussed and brady Cardia which is accompanied by premature ventricular tachycardia, QT prolongation, low cardiac output, and/or poor left ventricular function is discussed.
Novel If current inhibitor ivabradine: safety considerations.
TLDR
Ivabradine has been associated with a good safety profile during its clinical development and its safety will be further assessed by postmarketing surveillance and during on-going clinical trials.
Selective Inhibition of Cardiac Pacemaker (I f ) Current: the Role of Ivabradine in the Treatment of Angina
TLDR
Ivabradine is the representative of a new class of agents that exclusively reduce heart rate through inhibition of the sinoatrial pacemaker (I f ) current, and provides an attractive alternative to conventional therapy, whenever use of beta-blockers or calcium-channel blockers is contraindicated.
Pharmacotherapy changes following pacemaker implantation in patients with bradycardia–tachycardia syndrome
TLDR
Pacing by preventing drug-induced bradycardia increases the safety of pharmacotherapy and, thus, allows the intensification of those treatments, and atrial-based pacing may reduce atrial tachyarrhythmia burden, allowing reduction of rhythm and rate control.
Ivabradine as an Alternative Therapeutic Trial in the Therapy of Inappropriate Sinus Tachycardia
TLDR
The case of a young female patient with inappropriate sinus tachycardia where a sustained therapeutic success was achieved with ivabradine medication as an alternative therapeutic trial after various ineffective medications is reported.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 147 REFERENCES
Inappropriate Sinus Tachycardia: Evaluation and Therapy
TLDR
Radiofrequency catheter ablation of the superior portion of the sinus node shows promise as a useful alternative in patients with refractory symptoms and Pharmacologic approaches include beta blockers or verapamil.
Mechanism of ‘Inappropriate’ Sinus Tachycardia: Role of Sympathovagal Balance
TLDR
The findings suggest that the mechanism leading to IST is related to a primary sinus node abnormality characterized by a high IHR, depressed efferent cardiovagal reflex, and β-adrenergic hypersensitivity.
Specific bradycardic agents--a novel pharmacological class?
TLDR
It is suggested that substances from two different chemical groups, congeners of alinidine and falipamil, can be described as representatives of a novel and distinct pharmacological class: specific bradycardic agents (SBAs), characterized by a slowing of the sinus rate within physiological limits as the prominent cardiovascular effect.
Chronic nonparoxysmal sinus tachycardia in otherwise healthy persons.
TLDR
Seven patients had chronic, unexplained, nonparoxysmal sinus tachycardia, which suggested a defect in either sympathetic or vagal nerve control of resting heart rate, with or without an abnormality of intrinsic heart rate.
Inappropriate sinus tachycardia (IST): management by radiofrequency modification of sinus node.
TLDR
RF modification of the sinus node is feasible and effective for IST, and should be the treatment of choice in patients refractory to medical therapy.
Refractory paroxysmal sinus tachycardia: management by subtotal right atrial exclusion.
The effects of adenosine on sinus node reentrant tachycardia
TLDR
The effects of adenosine given during sinus node reentrant tachycardia suggest that sinus nodal tissue (as opposed to perinodal atrial tissue) is involved in the tachycardsia circuit and that these effects should be considered when adenoine is used as a diagnostic agent in narrow‐complex tachyCardia.
The Potential Role of Serotonin in the Pathogenesis of Neurocardiogenic Syncope and Related Autonomic Disturbances
  • B. Grubb, B. Karas
  • Medicine, Psychology
    Journal of Interventional Cardiac Electrophysiology
  • 2004
TLDR
Basic aspects of serotonin’s role in the central nervous system and in the regulation of cardiovascular function are reviewed, data suggeting its potential role in neurocardiogenic syncope is presented, and preliminary observations concerning the clinical use of the serotonin reuptake inhibitors in the management of these disorders are discussed.
Review: The Postural Orthostatic Tachycardia Syndrome: Current Concepts in Pathophysiology Diagnosis and Management
TLDR
The combined observations of multiple investigators found that these patients suffer from a distinct disorder which is most commonly referred to as the postural orthostatic tachycardia syndrome, which is designed to acquaint the interested reader with the clinical features of this condition, it's diagnosis and potential management options.
...
1
2
3
4
5
...